Steven J. Nigro

Steven J. Nigro

Auto-generated profile, based on publicly available information

Steven J. Nigro

School of Life and Environmental Sciences, The University of Sydney, NSW 2006, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Microbial Genomics
Verified
Journal Article
Open access
MHMohammad Hamidian
Mohammad Hamidian
SNSteven J. Nigro
Steven J. Nigro
Acinetobacter baumannii is a nosocomial pathogen that has emerged as a global threat because of high levels of resistance to many antibiotics, particularly those considered to be last-resort antibiotics, such as carbapenems. Although alterations in the efflux pump and outer membrane proteins can cause carbapenem resistance, the main mechanism is the acquisition of carbapenem-hydrolyzing oxacillinase-encoding genes. Of these, oxa23 is by far the most widespread in most countries, while oxa24 and oxa58 appear to be dominant in specific regions. Historically, much of the global spread of carbapenem resistance has been due to the dissemination of two major clones, known as global clones 1 and 2, although new lineages are now common in some parts of the world. The analysis of all publicly available genome sequences performed here indicates that ST2, ST1, ST79 and ST25 account for over 71 % of all genomes sequenced to date, with ST2 by far the most dominant type and oxa23 the most widespread carbapenem resistance determinant globally, regardless of clonal type. Whilst this highlights the global spread of ST1 and ST2, and the dominance of oxa23 in both clones, it could also be a result of preferential selection of carbapenem-resistant strains, which mainly belong to the two major clones. Furthermore, ~70 % of the sequenced strains have been isolated from five countries, namely the USA, PR China, Australia, Thailand and Pakistan, with only a limited number from other countries. These genomes are a vital resource, but it is currently difficult to draw an accurate global picture of this important superbug, highlighting the need for more comprehensive genome sequence data and genomic analysis.

10 January 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SNSteven J. Nigro
Steven J. Nigro
RHRuth Hall
Ruth Hall
The oxa23 gene encoding the OXA-23 carbapenemase (and several minor variants of it) is widespread in Acinetobacter baumannii clinical isolates and compromises treatment with carbapenem antibiotics. The gene is derived from the chromosome of Acinetobacter radioresistens where it is an intrinsic gene, here designated oxaAr. In A. baumannii and other Acinetobacter species, oxa23 is usually preceded by an IS, ISAba1, which supplies the strong promoter required for the gene to confer clinically relevant levels of resistance. The oxaAr gene appears to have been mobilized twice creating Tn2008 and Tn2008B, both of which consist of a single ISAba1 and an A. radioresistens-derived fragment. Tn2006 and Tn2009 are clearly derived from Tn2008B and are each made up of Tn2008B with an additional segment of unknown origin and an additional ISAba1, creating a compound transposon. Tn2006, Tn2008 and possibly Tn2008B are globally disseminated, while Tn2009 has as yet only been found in China. Of the four ISAba1-associated transposons, Tn2006 has been most frequently observed worldwide and Tn2006 in Tn6022, known as AbaR4, appears to contribute significantly to the dissemination of oxa23. Moreover, AbaR4, Tn2006, Tn2008 and Tn2009 have each been found in conjugative plasmids, further facilitating their spread.

17 May 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SNSteven J. Nigro
Steven J. Nigro
VPVirginia Post
Virginia Post
RHRuth Hall
Ruth Hall
To examine the distribution and context of aminoglycoside resistance genes in multiply antibiotic-resistant Acinetobacter baumannii isolates from Australia that are members of the global clone 2 and carry the blaOXA-23 gene conferring resistance to carbapenems. Sixty-one multiply antibiotic-resistant A. baumannii strains isolated between 2000 and 2010 at six Australian hospitals that belonged to global clone 2 and carried the blaOXA-23 gene were studied. Various molecular techniques were used to determine their relatedness and to detect antibiotic resistance genes and insertion sequences. Structures surrounding the aminoglycoside resistance genes were sequenced. The isolates all shared several antibiotic resistance genes, including the sul2 sulphonamide resistance gene, but varied in their pattern of resistance to aminoglycosides. The aminoglycoside resistance profiles of isolates were accounted for by four resistance genes—aadB, aacC1, aphA1b and aphA6—in various combinations. The aadB gene cassette was located at a secondary site on a 6 kb plasmid similar to pRAY. The aphA6 gene was in a transposon, TnaphA6, bounded by directly oriented copies of ISAba125. The aacC1 gene cassette in a class 1 integron and Tn6020 carrying aphA1b were always present together, but were not linked. Imipenem-resistant global clone 2 A. baumannii isolates containing blaOXA-23 have been present in Australian hospitals for at least 10 years. Variation in this global clone 2 type has occurred with the introduction of various aminoglycoside resistance genes carried on a small plasmid or within transposons.

10 August 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MHMohammad Hamidian
Mohammad Hamidian
SNSteven J. Nigro
Steven J. Nigro
RHRuth Hall
Ruth Hall
To determine the cause of resistance to the aminoglycosides gentamicin and tobramycin in Acinetobacter isolates and the location of the resistance genes. Australian Acinetobacter baumannii isolates were screened for resistance to aminoglycosides. PCR followed by restriction digestion of amplicons was used to detect genes and plasmids. Plasmids were isolated and examined by restriction digestion. Plasmid DNA sequences were determined and bioinformatic analysis was used to identify features. The sequence of the blaOXA-Ab gene and multilocus sequence typing were used to determine strain types. Isolates that exhibited resistance to gentamicin, kanamycin and tobramycin were of diverse strain types. These isolates all carried the aadB gene cassette, and in all but one the cassette was in a 6 kb plasmid similar to pRAY. The three plasmid sequences determined revealed multiple frame-shift differences in the available pRAY sequence that altered the reading frames. In pRAY*, mobA and mobC mobilization genes were identified, but no potential replication initiation protein was found. pRAY*-v1 differed from pRAY* by 66 single-base differences, and pRAY*-v2 included two insertion sequences, ISAba22, located upstream of the aadB gene cassette, and IS18-like, within ISAba22. The plasmid pRAY* and variants are widely distributed in Acinetobacter spp. and are the most common cause of resistance to gentamicin and tobramycin. Mobilization genes should assist in the dissemination of pRAY* and its variants.

23 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Johanna J. KenyonJohanna J. Kenyon
Johanna J. Kenyon
SNSteven J Nigro
Steven J Nigro
RHRuth Hall
Ruth Hall
Lipooligosaccharide (LOS) is a complex surface structure that is linked to many pathogenic properties of Acinetobacter baumannii. In A. baumannii, the genes responsible for the synthesis of the outer core (OC) component of the LOS are located between ilvE and aspS. The content of the OC locus is usually variable within a species, and examination of 6 complete and 227 draft A. baumannii genome sequences available in GenBank non-redundant and Whole Genome Shotgun databases revealed nine distinct new types, OCL4-OCL12, in addition to the three known ones. The twelve gene clusters fell into two distinct groups, designated Group A and Group B, based on similarities in the genes present. OCL6 (Group B) was unique in that it included genes for the synthesis of L-Rhamnosep. Genetic exchange of the different configurations between strains has occurred as some OC forms were found in several different sequence types (STs). OCL1 (Group A) was the most widely distributed being present in 18 STs, and OCL6 was found in 16 STs. Variation within clones was also observed, with more than one OC locus type found in the two globally disseminated clones, GC1 and GC2, that include the majority of multiply antibiotic resistant isolates. OCL1 was the most abundant gene cluster in both GC1 and GC2 genomes but GC1 isolates also carried OCL2, OCL3 or OCL5, and OCL3 was also present in GC2. As replacement of the OC locus in the major global clones indicates the presence of sub-lineages, a PCR typing scheme was developed to rapidly distinguish Group A and Group B types, and to distinguish the specific forms found in GC1 and GC2 isolates.

20 November 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SNSteven J. Nigro
Steven J. Nigro
DFDaniel N. Farrugia
Daniel N. Farrugia
Ian PaulsenIan Paulsen
Ian Paulsen
RHRuth Hall
Ruth Hall
To determine the context and location of antibiotic resistance genes in carbapenem- and aminoglycoside-resistant Acinetobacter baumannii global clone 2 (GC2) isolates carrying a class 1 integron. Isolates were from Sydney hospitals. Resistance to antibiotics was determined by disc diffusion. BLAST searches identified relevant DNA fragments in a draft genome sequence. PCR was used to assemble fragments and map equivalent regions. In two isolates belonging to GC2, WM99c and A91, the blaTEM gene, the class 1 integron carrying the aacC1-orfP-orfP-orfQ-aadA1 cassette array and sul1 gene, and the aphA1b gene in Tn6020 were each in segments flanked by IS26. These, together with a fourth IS26-flanked segment, formed a 19.5 kb genomic resistance island (GRI), designated AbGRI2-1, containing five copies of IS26. Part of this island was identical to part of the multiple antibiotic resistance region of AbaR-type islands found in global clone 1 (GC1). AbGRI2-1 has replaced a 40.9 kb segment found in the AB0057 genome. Related GRIs were identified in the same location in published GC2 genomes and appear to have arisen from AbGRI2-1 via IS26-mediated deletions. Like A91, WM99c carries ISAba1 upstream of ampC and Tn6167, an AbGRI1-type island in the chromosomal comM gene containing sul2, tet(B), strA and strB genes and blaOXA-23 in Tn2006. In WM99c, the chromosomal gene encoding OXA-Ab is interrupted by ISAba17. AbGRI2-1 is the largest so far of a new type of GRI designated AbGRI2 to distinguish them from the islands in comM in GC1 isolates (AbaR type) and in GC2 isolates (AbGRI1 type).